Highlights

• Trajan has assembled, through acquisitions and organic development, a portfolio spanning analytical consumables, devices and instruments used across laboratories in fields such as chromatography, sample preparation.
• The tension in Trajan’s numbers explains the share-price collapse.
• The obvious catalyst is the full-year result and outlook.
• The core risk is that the 27 August result confirms the market’s fears: continued losses, Margin pressure, or a cautious outlook could extend the decline, as.

Trajan has assembled, through acquisitions and organic development, a portfolio spanning analytical consumables, devices and instruments used across laboratories in fields such as…